Skip to main content
. 2019 Sep 16;2019:4873235. doi: 10.1155/2019/4873235

Figure 1.

Figure 1

Incidence of abnormal respiratory symptoms and respiratory diseases after MSE. (a) Incidence of abnormal respiratory symptoms after MSE. The highest was expectoration (18.7%), followed by shortness of breath (18.1%), wheezing (14.6%), chronic expectoration (14.4%), cough (12.6%), gasp for breath (5.7%), and chronic cough (4.9%). (b) Incidence of respiratory diseases after MSE. The highest was rhinitis (22.7%), followed by bronchitis (12.7%), pneumonia (8.3%), chronic bronchitis (2.6%), asthma (1.7%), and emphysema (0.1%).